Bart Filius

Board Member at ProQR Therapeutics

Bart has served on the Supervisory Board since 2019. He joined Galapagos in 2014 as Chief Financial Officer and added the role of Chief Operating Officer in 2017, he was promoted to President and Chief Operating Officer in 2021. Prior to joining Galapagos, Mr. Filius held a variety of executive positions at Sanofi, where he was Vice President, Chief Financial Officer Europe, Country Manager for The Netherlands, and Vice President for Mergers & Acquisitions. Prior to joining Sanofi, Mr. Filius was a strategy consultant at Arthur D. Little. Mr. Filius has an MBA degree from INSEAD and a bachelor’s degree in business from Nyenrode University.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ProQR Therapeutics

1 followers

ProQR Therapeutics develops RNA therapies to potentially transform the lives of patients suffering from inherited retinal diseases.


Industries

Employees

51-200

Links